- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06042361
Enhancing Equity in Smoke-free Housing
Enhancing Equity in Smoke-free Housing: Evidence-based Strategies to Support Implementation in Permanent Supportive Housing (PSH) Communities
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study aims are:
Aim 1): Identify adaptations for a smokefree housing implementation framework and identify opportunities to integrate these adaptations with ongoing behavioral health support, to meet the needs of residents living in Permanent Supportive Housing (PSH) (Phase 1).
Aim 2): The research team will pilot test the adapted implementation framework, including an implementation toolkit, to assess the acceptability, feasibility and effectiveness of the primary intervention provided to Property Managers (Phase 2).
Aim 3): Based on a synthesis of qualitative and quantitative evidence, the research team will further refine the smokefree implementation framework and toolkit, comprising modified versions of the "Implementation Guide", "Action Plan" and "Implementation Checklist", to support future needs of Permanent Supportive Housing communities (Phase 3).
The research team seeks to use the opportunity provided by smokefree housing implementation to minimize indoor smoking and encourage smoking cessation, and thus help move communities with a history of profound health disparities towards a more equitable, tobacco-free future. The impact of this project will be evident not only among smokers, but also non-smokers, children and the elderly who share residential communities with people supported by PSH programs.
If successful, the results of this work will be used to promote broader and more effective use of the smokefree PSH implementation framework in federally-assisted public and affordable housing communities nationally.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Harvard TH Chan School of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
The study setting is 6 affordable housing communities that include Permanent Supportive Housing (PSH) in Massachusetts, Maryland and New York (USA).
Inclusion Criteria:
- Adult residents of the six affordable housing communities who smoke or do not smoke tobacco, who receive or do not receive Permanent Supportive Housing services, and can complete a survey in English or Spanish.
- Adult residents of the six affordable housing communities who smoke or do not smoke tobacco, who receive or do not receive Permanent Supportive Housing services, and can participate in a focus group discussion in English.
- Property Managers (or their designated appointees) of the six affordable housing communities where the research will be conducted and able to receive the intervention and participate in the qualitative interviews in English.
- Caseworkers who are dedicated health workers who provide behavioral health support (mental health and substance use support interventions) to residents at each of the six properties and who can receive the intervention and participate in the qualitative interviews in English.
Exclusion Criteria:
- Those unable to speak English or Spanish.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Intervention
All participants will receive the intervention of the Smokefree Implementation Framework and Toolkit
|
Framework and toolkit that includes "Implementation Guide", "Action Plan", and "Implementation Checklist" that supports the needs of Permanent Supportive Housing communities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Intervention Measure (AIM)
Time Frame: Pre-intervention through 6 months post intervention
|
The Smokefree Implementation Framework and Toolkit is acceptable to implement in Permanent Supportive Housing communities.
Measured using 4-items from the AIM.
|
Pre-intervention through 6 months post intervention
|
|
Feasibility of Intervention Measure (FIM)
Time Frame: Pre-intervention through 6 months post intervention
|
The Smokefree Implementation Framework and Toolkit is feasible to implement in Permanent Supportive Housing communities.
Measured using 4-items from the FIM.
|
Pre-intervention through 6 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ambient second-hand smoke in common indoor areas
Time Frame: Pre-intervention through 6 months post intervention
|
Monitored using passive nicotine dosimetry monitors placed in common areas
|
Pre-intervention through 6 months post intervention
|
|
Residents' self-reported exposure to secondhand smoke
Time Frame: Pre-intervention through 6 months post intervention
|
Self-reported exposure to secondhand smoke (smell or sight) in the home or around the property, will be assessed with two questions in survey form.
|
Pre-intervention through 6 months post intervention
|
|
Behavior of residents who smoke
Time Frame: Pre-intervention through 6 months post intervention
|
Self-reported behavior of smoking (cigarettes/day in the past 30 days) of residents who smoke
|
Pre-intervention through 6 months post intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vaughan Rees, PhD, Harvard University School of Public Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB23-0415
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
Loma Linda UniversityUniversity of California, San Francisco; Riverside University Health System...RecruitingTobacco Use | Tobacco Use Cessation | Tobacco Use in ChildbirthUnited States
-
University of Mississippi Medical CenterNot yet recruitingTobacco Cessation
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
University of FloridaRecruitingTobacco Use | Nicotine UseUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Harvard School of Public Health (HSPH)Boston University; Dana-Farber Cancer Institute; Dimagi Inc.; Narotam Sekhsaria...Completed
Clinical Trials on Smokefree Implementation Framework and Toolkit
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)CompletedPregnancy RelatedUnited States
-
University of British ColumbiaThe Arthritis Society, Canada; Centre for Aging SMART; Centre for Advancing Health...Not yet recruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipCanada
-
Université de SherbrookeActive, not recruitingCardiovascular Diseases | Smoking | Hypertension | Obesity | Diabetes Mellitus, Type 2 | DyslipidemiasCanada
-
VA Office of Research and DevelopmentVA Boston Healthcare SystemCompleted
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH); Praxis, Inc.CompletedMood Disorders | Anxiety DisordersUnited States
-
VU University of AmsterdamLondon School of Hygiene and Tropical Medicine; Northumbria University; Region... and other collaboratorsCompletedTailored Implementation: Online ItFits-toolkit | Implementation as UsualNetherlands, Albania, Australia, Denmark, France, Germany, Italy, Kosovo, Spain
-
Hidde van der PloegHannover Medical School; Institut Català d'Oncologia; German Cancer Research... and other collaboratorsEnrolling by invitationFocus of Study: Tailored ImplementationIreland, Germany, Spain, Australia, Albania, Italy, Netherlands, Ukraine, United Kingdom
-
Mayo ClinicCompletedDiabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, OsteoporosisUnited States
-
Indiana UniversityCompleted
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity Disorder SymptomsUnited States